‘Genetic signatures’ may predict prostate cancer

October 9, 2012
blood test
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.
Researchers have identified genetic “signatures” for aggressive prostate cancer (the second most common cause of death in men, after lung cancer). The findings could one day help improve patient treatment and outcomes. These genetic patterns were identified from simple blood tests, with no tissue or biopsy was needed.

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend